One PD mice group was treated with both STN-DBS and 3BDO-mTOR activator and did not show any improvement in motor performance or preserved dopaminergic neurons, indicating a blocking effect on the STN-DBS (Fig. 2c, d–h) (n = 8; n = 6). The gene discussed is MTOR; the disease is Parkinson disease.